Addex Therapeutics Alternatives & Competitors
12 companies similar to Addex Therapeutics — Allosteric modulators for Human Health
Companies similar to Addex Therapeutics
Gain Therapeutics
Unfolding the next generation of allosteric small molecule therapies to meet patient needs...
Bethesda, United States
Allyx Therapeutics
Protecting Synapses and Reversing Neurodegeneration
New Haven, United States
Newron Pharmaceuticals SpA
The Specialist in CNS Drug Development
Bresso, Italy
Asceneuron SA
Targeting the root cause of neurodegeneration
Lausanne, Switzerland
Track all Addex Therapeutics competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Satori Pharmaceuticals
Pioneering advanced therapies for Alzheimer's, Parkinson's, and other neurodegenerative di...
Lys Therapeutics
First-in-class biotherapies against neurological diseases. Targeting neuroinflammation t...
Lyon, France
Cerebral Therapeutics, Inc.
A clinical stage pharmaceutical company developing innovative treatments for neurological...
Aurora, United States
Jupiter Neurosciences, Inc.
A clinical-stage drug platform company focused on treating neuroinflammation.
Jupiter, United States
MindMed
MindMed is a clinical-stage biopharma company developing novel products to treat brain hea...
New York, United States
Seelos Therapeutics, Inc.
A clinical-stage biopharmaceutical company focused on central nervous system disorders and...
New York, United States
Neurolixis
New treatments for central nervous system disorders
Park Ridge, United States
Biscayne Neurotherapeutics Inc
A clinical-stage biotechnology company advancing innovative therapies for challenging neur...
Miami, United States
About Addex Therapeutics
Addex Therapeutics is a Swiss-based biotechnology company founded in 2002 and listed on the SIX Swiss Exchange and NASDAQ Capital Market under the ticker symbol "ADXN." The company focuses on the development and commercialization of allosteric modulators, a novel class of orally available small molecule drugs, for the...
Allosteric Modulators, Neurological Disorders, Pharmaceutical, Clinical-stage, Drug Development, Parkinson's Disease, Dyskinesia, Epilepsy, Addiction Treatment, Preclinical Programs, MGlu Receptors, GABAB Receptors, PTSD, Neurodegenerative Disorders, NASDAQ
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Addex Therapeutics and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Addex Therapeutics on 11 Sep 2024. The 12 companies listed here were last checked between 12 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
